Summary
UnitedHealth Group (UNH) reported solid financial results for the nine months ending September 30, 2014, with total revenues increasing by 6% to $97.04 billion. Net earnings attributable to common shareholders saw a slight decrease of 2% to $4.11 billion, largely influenced by the new nondeductible insurance industry tax (Industry Tax) and Medicare Advantage rate cuts, which collectively impacted earnings by over $1.3 billion for the full year. The company demonstrated strong operational execution, with earnings from operations increasing by 5% year-over-year. The company continues to navigate the evolving healthcare landscape, including the implementation of the Affordable Care Act (ACA), and is strategically adapting its offerings and pricing to address regulatory changes and market dynamics. UnitedHealth Group's diversified business model, with its two main platforms, UnitedHealthcare and Optum, continues to drive growth. Optum revenues, in particular, showed robust growth of 26%, highlighting the success of its information and technology-enabled health services. The company also returned significant capital to shareholders through share repurchases and dividend increases, signaling confidence in its financial strength and future prospects. Despite facing headwinds from regulatory changes and increased taxes, UNH's operational performance and strategic positioning suggest resilience and a continued ability to generate value for its investors.
Financial Highlights
54 data points| Revenue | $32.76B |
| Cost of Revenue | $955.00M |
| Gross Profit | $31.80B |
| SG&A Expenses | $5.44B |
| Operating Expenses | $29.86B |
| Operating Income | $2.90B |
| Interest Expense | $152.00M |
| Net Income | $1.60B |
| EPS (Basic) | $1.65 |
| EPS (Diluted) | $1.63 |
| Shares Outstanding (Basic) | 969.00M |
| Shares Outstanding (Diluted) | 982.00M |
Key Highlights
- 1Total revenues grew 6% to $97.04 billion for the nine months ended September 30, 2014.
- 2Net earnings attributable to common shareholders decreased by 2% to $4.11 billion for the nine months ended September 30, 2014.
- 3The company incurred a significant impact from the nondeductible Industry Tax and Medicare Advantage rate cuts, estimated at over $1.3 billion for the full year 2014.
- 4Optum segment revenues increased significantly by 26% for the nine months ended September 30, 2014, driven by OptumRx and OptumHealth.
- 5UnitedHealthcare Community & State revenues saw substantial growth of 26% for the nine months ended September 30, 2014, largely due to Medicaid expansion under the ACA.
- 6The company repurchased $3.0 billion of common stock year-to-date and increased its quarterly cash dividend.
- 7Total assets grew to $85.43 billion as of September 30, 2014, compared to $81.88 billion as of December 31, 2013, primarily driven by increases in receivables and goodwill.